Safety, tolerability and discontinuation causes of sacubitril/valsartan treatment in patients with heart failure and reduced ejection fraction attending to an outpatient heart failure clinic.
27 May 2019 (08:30 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Hospital Universitari Parc Tauli de Sabadell, Sabadell (Spain)
56 More presentations in this session
Access the full session
The Event
Heart Failure 2019
27 May 2019
08:30 CET
